Cart
sales@molnova.com
Sodium Nitroprusside Dihydrate
CAS No. 13755-38-9
Sodium Nitroprusside Dihydrate( Sodium nitroprusside dihydrate | Sodium Nitroferricyanide(III) Dihydrate )
Catalog No. M17986 CAS No. 13755-38-9
Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 41 | In Stock |
|
| 1G | 42 | In Stock |
|
Biological Information
-
Product NameSodium Nitroprusside Dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionSodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
-
DescriptionSodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.(In Vitro):Nitroprusside disodium dehydrate sensitizes human gastric cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
-
In VitroNitroprusside disodium dehydrate sensitizes human gastric cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
-
In Vivo——
-
SynonymsSodium nitroprusside dihydrate | Sodium Nitroferricyanide(III) Dihydrate
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptorguanylate cyclase
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number13755-38-9
-
Formula Weight297.95
-
Molecular FormulaC5H4FeN6Na2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 46 mg/mL; 154.39 mM
-
SMILES[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Erlotinib hydrochlor...
Erlotinib (CP-358774;OSI-774;NSC 718781) is a potent, selective inhibitor of EGFR with IC50 of 2 nM.
-
Falnidamol
Falnidamol (BIBX 1382) is an orally active, selective EGFR tyrosine kinase inhibitor with an IC50 of 3 nM. It displays >1000-fold lower potency against ErbB2 (IC50=3.4 μM) and other related tyrosine kinases (IC50>10 μM).
-
GSK-LSD1 dihydrochlo...
GSK-LSD1 2HCl is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B).
